Antiepileptic drugs and breastfeeding

56Citations
Citations of this article
144Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction. This review provides a synopsis for clinicians on the use of antiepileptic drugs (AEDs) in the breastfeeding mother. Methods. For each AED, we collected all retrievable data from Hale's "Medications and Mother Milk" (2012), from the LactMed database (2013) of the National Library of Medicine, and from a MedLine Search of relevant studies in the past 10 years. Results: Older AEDs, such as carbamazepine, valproic acid, phenytoin, phenobarbital, primidone are considered to have a good level of safety during lactation, due to the long term clinical experience and the consequent amount of available data from the scientific literature. On the contrary, fewer data are available on the use of new AEDs. Therefore, gabapentin, lamotrigine, oxcarbazepine, vigabatrin, tiagabine, pregabalin, leviracetam and topiramate are compatible with breastfeeding with a less documented safety profile. Ethosuximide, zonisamide and the continue use of clonazepam and diazepam are contraindicated during breastfeeding. Conclusions: Although the current available advice on the use of AEDs during breastfeeding, given by different accredited sources, present some contradictions, most AEDs can be considered safe according to our review. © 2013 Davanzo et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Davanzo, R., Dal Bo, S., Bua, J., Copertino, M., Zanelli, E., & Matarazzo, L. (2013). Antiepileptic drugs and breastfeeding. Italian Journal of Pediatrics, 39(1). https://doi.org/10.1186/1824-7288-39-50

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free